Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02359734 · ClinicalTrials.gov registry record

A National Study of Intravenous Medication Errors

A clinical trial, sponsored by Brigham and Women's Hospital.

Completed
Registry status
900
Enrollment target

NCT02359734: Completed study, sponsored by Brigham and Women's Hospital.

NCT02359734 is a clinical trial that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 900 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02359734 has completed, sponsored by Brigham and Women's Hospital.

COMPLETED
Registry status
900 participants
Enrollment target

Study Summary

To identify the key issues around use of computerized patient infusion devices (called "smart pumps"). To develop strategies that will improve the prevention of intravenous errors that will be broadly applicable. The investigators will conduct a national study using the general methodology developed by Husch et al. to allow a rapid assessment of the frequency and types of medication errors at an institution. The key questions the investigators will address are: 1. What are the frequency and types of intravenous medication errors? 2. How much variability is there by frequency and type among settings? 3. After review of the initial data, what strategies appear to have the greatest potential for reducing intravenous medication error frequency? 4. How effective is an intervention including a bundle of these strategies at multiple sites?

Primary Outcome

The same medication but the dose is different from the prescribed order.

Interventions

  • OTHER Smart pump safety Intervention bundle for improving IV medication administration process with smart pump

Trial Details

FieldValue
Enrollment Target 900 participants
Start Date 2012-04
Est. Completion 2015-12
Brigham and Women's Hospital

937 total trials

What the finished NCT02359734 record still lists

NCT02359734 is an observational study that tracks outcomes without assigning an intervention. The registered 900 participants enrollment target is mid-sized for trials with a published cap.

The record links to 0 conditions, and to 1 intervention - of which Smart pump safety Intervention bundle for improving IV medication administration process with smart pump is the first listed.

NCT02359734 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02359734 about?

NCT02359734 is a clinical study titled "A National Study of Intravenous Medication Errors". To identify the key issues around use of computerized patient infusion devices (called "smart pumps"). To develop strategies that will improve the prevention of intravenous errors that will be broadly applicable. The investigators will conduct a national study using the general methodology develop...

What is the current status of trial NCT02359734?

This trial is currently completed. The enrollment target is 900 participants. The study started on 2012-04. Estimated completion is 2015-12.

What interventions are being tested in trial NCT02359734?

The interventions under investigation include: Smart pump safety Intervention bundle for improving IV medication administration process with smart pump (OTHER).

Who is sponsoring clinical trial NCT02359734?

This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02352116 · 900 participants · NA

    Evaluation of Post-PACU Pain Management in Pediatric Surgery

  • NCT02414347 · 900 participants

    F 18 T807 Tau PET Imaging of Alzheimer's Disease

  • NCT02670408 · 900 participants

    Diagnostic and Therapeutic Applications of Microarrays in Heart Transplantation

  • NCT02960022 · 900 participants · Phase 2

    A Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02359734, the US trial registry maintained by the National Library of Medicine. NCT02359734 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.